Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 17/20 | 1.00 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.62 |
| ▸ | CX3CR1 | P49238 | 8/20 | 0.57 |
| ▸ | PAK4 | O96013 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL841880 | 0.89 | CXCR2 (0.79) | CXCR2CXCR1CX3CR1PAK4 | |
| SCHEMBL6865476 | 0.88 | CXCR2 (0.79) | CXCR2CX3CR1PAK4 | |
| SCHEMBL6866078 | 0.86 | CXCR2 (0.75) | CXCR2CX3CR1PAK4 | |
| SCHEMBL6865864 | 0.85 | CXCR2 (0.73) | CXCR2CX3CR1PAK4 | |
| SCHEMBL6864490 | 0.85 | PAK4 (0.78) | CXCR2CX3CR1PAK4 | |
| SCHEMBL6866174 | 0.84 | CXCR2 (0.81) | CXCR2CX3CR1 | |
| SCHEMBL6866720 | 0.84 | CXCR2 (0.90) | CXCR2CX3CR1 | |
| SCHEMBL6859464 | 0.84 | CXCR2 (0.72) | CXCR2CX3CR1PAK4 | |
| SCHEMBL6865141 | 0.83 | CXCR2 (1.00) | CXCR2CX3CR1 | |
| SCHEMBL6866490 | 0.83 | CXCR2 (1.00) | CXCR2CX3CR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806273-B1 | 5-THIO-THIAZOLO(4,5-D)PYRIMIDIN-7-YL DERIVATIVES; CHEMOKINE RECEPTOR (ESPECIALLY CXCR2) ACTIVITY MODULATORS | ASTRAZENECA AB (SE) | 2004-10-19 | — | — | US | claimed |
| EP-1104425-B1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | claimed |
| EP-1104425-A1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | AstraZeneca AB (SE) | 2001-06-06 | — | — | EP | claimed |
| WO-2000009511-A1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2000-02-24 | — | — | WO | claimed |
| US-6806273-B1 | 5-THIO-THIAZOLO(4,5-D)PYRIMIDIN-7-YL DERIVATIVES; CHEMOKINE RECEPTOR (ESPECIALLY CXCR2) ACTIVITY MODULATORS | ASTRAZENECA AB (SE) | 2004-10-19 | — | — | US | disclosed |
| EP-1104425-B1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | disclosed |
| EP-1104425-A1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | AstraZeneca AB (SE) | 2001-06-06 | — | — | EP | disclosed |
| WO-2000009511-A1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2000-02-24 | — | — | WO | disclosed |